<DOC>
	<DOCNO>NCT00335101</DOCNO>
	<brief_summary>The study evaluate compare effect kidney function three iodinate contrast medium ( CM ) patient risk kidney damage evaluate serum creatinine ( Scr ) concentration three day CM administration .</brief_summary>
	<brief_title>Renal Effects Three Iodinated Contrast Media ( CM ) Patients Risk Undergoing Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects combination DM ( type I II ) renal impairment ( RI ) , define SCr ≥150 µmol/L ( 1.7 mg/dL ) men ≥133 µmol/L ( 1.5 mg/dL ) woman creatinine clearance ( CrCl ) ≤50 mL/min calculate accord CockroftGault formula , refer coronary angiography without PCI . Concurrent administration potentially nephroprotective nephrotoxic drug allow . Subjects undergoing dialysis kidney transplantation CrCl &lt; 20 mL/min include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Coronary Artery Disease ( CAD ) , Renal Impairment , Serum creatinine ( SCr ) , Iodixanol , Ioversol , Iopromide , Contrast Induced Nephropathy ( CIN )</keyword>
</DOC>